Skip to main content
CDC Website

Tuberculosis Drug Information Guide

The Tuberculosis Drug Information Guide, 2nd edition, is derived from Drug-Resistant Tuberculosis: A Survival Guide for Clinicians (2nd edition) produced in 2008. Two additional drugs, ofloxacin and clarithromycin (which are used primarily outside of the US), have been included. This Guide can help any physician, nurse, or pharmacist who participates in the management of patients with TB or LTBI.

Author:
California Department of Public Health, Curry International TB Center, Curry International TB Center, California Department of Public Health, Tuberculosis Control Branch, CDHS DCDC VRDL
Format:
Manual
Publication Date:
2012
ID:
33798
  • TB
  • Treatment- Adverse Reactions
  • Treatment - Latent TB infection (Inactive TB)
  • Treatment- TB Disease
  • TB Treatment
  • Treatment- Medication Information
Was this page helpful? Give Feedback